[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

May 2019 - January 1920

Decade

Year

Issue

January 1, 2011, Vol 147, No. 1, Pages 11-142

Editorial

On Reducing the Need to Excise Nevi

Abstract Full Text
Arch Dermatol. 2011;147(1):105-106. doi:10.1001/archdermatol.2010.397
Study

Histopathologic Study of Hidradenitis Suppurativa Following Long-Pulsed 1064-nm Nd:YAG Laser Treatment

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):21-28. doi:10.1001/archdermatol.2010.245
ObjectiveTo assess clinical and histopathologic changes occurring after long-pulsed 1064-nm Nd:YAG laser treatment of hidradenitis suppurativa (HS).DesignProspective, controlled clinical and histologic study of patients with Hurley stage II HS disease.SettingOutpatient dermatology department at Henry Ford Hospital, Detroit, Michigan.ParticipantsNineteen patients with Fitzpatrick skin types II to VI with Hurley stage II HS lesions of the axilla and groin.InterventionsTwo monthly laser sessions were performed using the long-pulsed 1064-nm Nd:YAG laser.Main Outcome MeasureClinical response was scored using the modified Sartorius scale for HS reflecting Lesion Area and Severity Index (LASI). Histologic changes were examined before treatment and 1 week, 1 month, and 2 months after treatment.ResultsThe percentage change in HS severity after 2 sessions of laser treatment was –31.6 over all anatomic sites (P < .005), –24.4 for the axillary site (P = .008), and –36.8 for the inguinal site (P = .001). Histologic changes corresponded to clinical response. Findings from serial biopsy specimens showed increased inflammation at 1 week after treatment and decreased inflammation with resulting fibrosis and scarring at 1 month and 2 months after treatment.ConclusionsThe long-pulsed 1064-nm Nd:YAG laser is a novel effective treatment option for HS. Our histopathologic data suggest that HS is primarily a follicular disorder. The Nd:YAG laser penetrates for selective photothermolysis of the follicular unit and destruction of organized inflammatory lesions in the superficial to mid dermis. Our study offers insight into the pathogenesis of HS and the mechanism of the Nd:YAG laser in treatment of patients with this chronic, debilitating disease.

Development of a Photographic Scale for Consistency and Guidance in Dermatologic Assessment of Forearm Sun Damage

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):31-36. doi:10.1001/archdermatol.2010.392

Skin Cancer Screening by Dermatologists, Family Practitioners, and Internists: Barriers and Facilitating Factors

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):39-44. doi:10.1001/archdermatol.2010.414

Dermoscopy of Patients With Multiple Nevi: Improved Management Recommendations Using a Comparative Diagnostic Approach

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):46-49. doi:10.1001/archdermatol.2010.389
skINsight

In Vivo Imaging of Lichen Nitidus With Confocal Laser Scanning Microscopy

Abstract Full Text
Arch Dermatol. 2011;147(1):142. doi:10.1001/archdermatol.2010.386
Evidence-Based Dermatology: Research Commentary

Validation of Psoriasis Clinical Severity and Outcome Measures: Searching for a Gold Standard

Abstract Full Text
Arch Dermatol. 2011;147(1):95-98. doi:10.1001/archdermatol.2010.242

Effectiveness of Oral Ivermectin and Malathion Lotion for Difficult-to-Treat Head Lice

Abstract Full Text
Arch Dermatol. 2011;147(1):98-100. doi:10.1001/archdermatol.2010.400
The Cutting Edge: Challenges in Medical and Surgical Therapies

The Lattice Stitch Technique

Abstract Full Text
Arch Dermatol. 2011;147(1):17-20. doi:10.1001/archdermatol.2010.235
Research Letter

A Pilot Study of Etanercept Treatment for Pemphigus Vulgaris

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):117-118. doi:10.1001/archdermatol.2010.409

Skin Conditions That Bring Patients to Emergency Departments

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):118-120. doi:10.1001/archdermatol.2010.246

Detection of Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Chronic Graft-vs-Host Disease and Immunosuppression

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):120-122. doi:10.1001/archdermatol.2010.383

Botulinum Toxin Type A vs Type B for Axillary Hyperhidrosis in a Case Series of Patients Observed for 6 Months

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):122-123. doi:10.1001/archdermatol.2010.408

Neurogenic Rosacea: A Distinct Clinical Subtype Requiring a Modified Approach to Treatment

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):123-126. doi:10.1001/archdermatol.2010.413
Observation

Dermoscopy in Skin Self-examination: A Useful Tool for Select Patients

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):53-58. doi:10.1001/archdermatol.2010.387

Reflectance Confocal Microscopy of the Yellow Dot Pattern in Alopecia Areata

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):61-64. doi:10.1001/archdermatol.2010.288

Paraneoplastic Pemphigus Herpetiformis With IgG Antibodies to Desmoglein 3 and Without Mucosal Lesions

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):67-71. doi:10.1001/archdermatol.2010.362

Evolution of Nevi During Treatment With Natalizumab: A Prospective Follow-up of Patients Treated With Natalizumab for Multiple Sclerosis

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):72-76. doi:10.1001/archdermatol.2010.243
BackgroundNatalizumab is a monoclonal antibody directed against α4 integrin used in the treatment of multiple sclerosis (MS). Four cases of melanomas occurring in patients prescribed natalizumab to treat MS were recently reported. Although some fundamental data suggested that α4β1 integrin could be linked to the invasiveness of melanoma, none showed any relation with the transformation of melanocytes.ObservationsWe performed a prospective follow-up of a cohort of patients with MS treated with natalizumab to assess the evolution of nevi under treatment. Clinical dermatologic examination and videodermoscopy were performed every 6 months. Nevi were compared side-by-side with baseline photographs, and histologic analysis was proposed based on clinical and dermoscopic criteria. Forty-four patients were included, and 248 nevi were examined and followed up. The mean duration of follow-up was 14 months (range, 6-20 months). Seventeen lesions (6.8%) showed modifications over time. Only 12 (4.8%) presented substantial dermoscopic changes. Five lesions were removed. All of them were classified as benign after histologic examination.ConclusionsOur results showed the same rate of clinical and dermoscopic changes of nevi during treatment with natalizumab compared with the spontaneous evolution of nevi reported in literature. In accordance with fundamental data, those results suggest that the inhibition of the α4 integrin does not promote the transformation of melanocytic lesions.
Notable Notes

Syphilis in Greek Poetry: A Uniquely Positive Perspective

Abstract Full Text
Arch Dermatol. 2011;147(1):28. doi:10.1001/archdermatol.2010.388

Articles of Faith Variant Nomofungusumungus!

Abstract Full Text
Arch Dermatol. 2011;147(1):58. doi:10.1001/archdermatol.2010.344
The Best of the Best

Top-Accessed Article: Keratosis Pilaris Rubra

Abstract Full Text
Arch Dermatol. 2011;147(1):20. doi:10.1001/archdermatol.2010.353
This Month in Archives of Dermatology

This Month in Archives of Dermatology

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):13. doi:10.1001/archdermatol.2010.398
Archives a Century Ago

An Unusual Case of Tinea Versicolor.

Abstract Full Text
Arch Dermatol. 2011;147(1):16. doi:10.1001/archdermatol.2010.391
Practice Gaps
Archives Web Quiz Winner

October 2010 Archives Web Quiz Winner

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):45. doi:10.1001/archdermatol.2010.415

Failure to Compare Dermoscopy Findings of Pigmented Lesions on Your Patient: Comment on “Dermoscopy of Patients With Multiple Nevi”

Abstract Full Text
Arch Dermatol. 2011;147(1):50. doi:10.1001/archdermatol.2010.390
Evidence-Based Dermatology: Review

Etanercept: An Overview of Dermatologic Adverse Events

Abstract Full Text
Arch Dermatol. 2011;147(1):79-94. doi:10.1001/archdermatol.2010.410
Evidence-Based Dermatology: Critically Appraised Topic

Is Topical Monotherapy Effective for Localized Pyoderma Gangrenosum?

Abstract Full Text
free access
Arch Dermatol. 2011;147(1):101-103. doi:10.1001/archdermatol.2010.393
Off-Center Fold

Pruritic Indurated Plaques on the Legs of a 62-Year-Old Woman—Quiz Case

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.401-a

Pruritic Indurated Plaques on the Legs of a 62-Year-Old Woman—Diagnosis

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.401-b

Tender Papules and Plaques Adjacent to a Scar—Quiz Case

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.402-a

Tender Papules and Plaques Adjacent to a Scar—Diagnosis

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.402-b

Necrotic Papules on the Thigh of a 76-Year-Old Woman With Prolonged Fever—Quiz Case

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.403-a

Necrotic Papules on the Thigh of a 76-Year-Old Woman With Prolonged Fever—Diagnosis

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.403-b

Generalized Annular Bullous Eruption—Quiz Case

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.404-a

Generalized Annular Bullous Eruption—Diagnosis

Abstract Full Text
Arch Dermatol. 2011;147(1):109-114. doi:10.1001/archdermatol.2010.404-b
Correspondence

Bullous Amyloidosis Complicated by Cellulitis and Sepsis: A Case Report

Abstract Full Text
Arch Dermatol. 2011;147(1):126-127. doi:10.1001/archdermatol.2010.381

Clear Cell Papulosis of the Skin: Acquired Hypomelanosis

Abstract Full Text
Arch Dermatol. 2011;147(1):128-129. doi:10.1001/archdermatol.2010.382

A Case of Epithelioid Angiosarcoma of the Scalp Treated With Paclitaxel and Radiotherapy

Abstract Full Text
Arch Dermatol. 2011;147(1):129-130. doi:10.1001/archdermatol.2010.394

Acneiform Follicular Mucinosis Responding to Hydroxychloroquine

Abstract Full Text
Arch Dermatol. 2011;147(1):130-131. doi:10.1001/archdermatol.2010.405

Effectiveness of Infliximab for Intralymphatic Histiocytosis With Rheumatoid Arthritis

Abstract Full Text
Arch Dermatol. 2011;147(1):131-133. doi:10.1001/archdermatol.2010.407

Invasive Squamous Cell Carcinoma and Sorafenib in a Black Patient

Abstract Full Text
Arch Dermatol. 2011;147(1):133-134. doi:10.1001/archdermatol.2010.395

Exudative, Nonhealing Scalp: A Complication of Systemic Chemotherapy With Capecitabine and Bevacizumab

Abstract Full Text
Arch Dermatol. 2011;147(1):134-135. doi:10.1001/archdermatol.2010.396
×